Taking Better Aim at Tumors

(DGIwire) – When it comes to treating cancer, chemotherapy and immunotherapy have proven to be powerful within certain limits. Take immunotherapy: Despite its great promise, it doesn’t help every patient to which it is given—and its track record of success is uneven among different cancers. So notes Douglas J. Swirsky, President and CEO of Rexahn […]

Will the ‘Immunotherapy Explosion’ Continue?

(DGIwire) – The field of immunotherapy—in which a patient’s immune system is made to fight against cancer cells—is exploding. This opinion was recently expressed by Dr. James Allison, the co-recipient of the 2018 Nobel Prize in Medicine, in Cancer Research Analyst, the official blog of the American Association for Cancer Research. For the first time, […]

What’s Next in the Fight Against Pancreatic Cancer?

(DGIwire) – Sobering news from the world of medicine: More than 56,000 Americans will be diagnosed with pancreatic cancer in 2019, according to a recent estimate by the American Cancer Society. This represents a two percent increase over the previous year’s diagnoses. While the ACS also states that the disease’s five-year survival rate continues to […]

Why the Future of Cancer Immunotherapy Looks Bright

(DGIwire) – Cancer immunotherapy is a field of medicine that aims to identify treatments for cancer by enhancing the human body’s immune response. According to a recent review article in Frontiers of Immunology, this form of treatment has witnessed a surge in interest in recent years and is likely to transform the treatment of many […]

A Nobel-Worthy Advance: Battling Cancer by Retooling the Body’s Immune Response

(DGIwire) – Immunotherapy—the method of harnessing the body’s own immune system to attack and kill cancer cells—is not just one of the most exciting frontiers in medicine today; it is now officially Nobel Prize-winning work. As recently reported by the Pancreatic Cancer Action Network and many other media outlets, two pioneers in the field—Drs. James […]

3 Challenges Facing Immunotherapy and How RNAi Might Help

(DGwire) – The battle against solid tumors in cancer immunotherapy is engaging some of the brightest minds in medicine. While predictions suggest the immunotherapy market will be worth about $25 billion by 2030, there are still some hurdles to overcome in the effort to improve treatment options, including: Boosting the immune system to fight: As […]

close